Risk-reducing total Gastrectomy for germline mutations in E-cadherin (CDH1): Pathologic findings with clinical implications

American Journal of Surgical Pathology

Volumn 32, Issue 6, 2008, Pages 799-809

  Rogers, William M ^a   Dobo, Erika ^a   Norton, Jeffrey A ^a,b   Van Dam, Jacques ^a   Jeffrey, R Brooke ^a   Huntsman, David G ^c   Kingham, Kerry ^a   Chun, Nicki ^a   Ford, James M ^a,b   Longacre, Teri A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

CDH1 germline mutation; E cadherin; Endoscopic screening; Hereditary gastric cancer; Prophylactic gastrectomy; Signet ring carcinoma

Indexed keywords

BETA CATENIN; KI 67 ANTIGEN; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PROTEIN EXPRESSION; RISK REDUCTION; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TOTAL STOMACH RESECTION; GASTRECTOMY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; RISK FACTOR; STOMACH TUMOR;

ADULT; AGED; CADHERINS; CARCINOMA, SIGNET RING CELL; FEMALE; GASTRECTOMY; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 46249087094     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31815e7f1a     Document Type: Article

References (27)

1. Blair V, Martin I, Shaw D, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006;4: 262-275.
2. Brooks-Wilson AR, Kaurah P, Suriano G, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508-517.
3. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36: 873-880.
4. Carneiro F, Huntsman DG, Smyrk TC, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004; 203:681-687.
5. Charlton A, Blair V, Shaw D, et al. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut. 2004;53:814-820.
6. Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer. 2001;92:181-187.
7. Daly MB, Axilbund JE, Bryant E, et al. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2006;4: 156-176.
8. Dunbier A, Guilford P. Hereditary diffuse gastric cancer. Adv Cancer Res. 2001;83:55-65.
9. Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germline E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998;58:4086-4089.
10. Ghandur-Mnaymneh L, Paz J, Roldan E, et al. Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma. Am J Surg Pathol. 1988;12:96-114.
11. Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol. 2003;14:1705-1713.
12. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402-405.
13. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999;14:249-255.
14. Jass JR. A classification of gastric dysplasia. Histopathology. 1983;7: 181-193.
15. Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007;297:2360-2372.
16. Keller G, Vogelsang H, Becker I, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol. 1999;155:337-342.
17. Lynch HT, Grady W, Suriano G, et al. Gastric cancer: new genetic developments. J Surg Oncol. 2005;90:114-133. Discussion 133.
18. Ming SC. Dysplasia of gastric epithelium. Front Gastrointest Res. 1979;4:164-172.
19. Nakamura E, Sugihara H, Bamba M, et al. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol. 2005; 205:349-358.
20. Norton JA, Ham CM, Van Dam J, et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrect-omy to treat hereditary diffuse gastric cancer. Ann Surg. 2007;245: 873-879.
21. Oliveira C, Moreira H, Seruca R, et al. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family. Virchows Arch. 2005;446:181-184.
22. Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001; 121:1348-1353.
23. Richards FM, McKee SA, Rajpar MH, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999;8:607-610.
24. Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut. 2005;54:461-468.
25. Shinmura K, Kohno T, Takahashi M, et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis. 1999;20: 1127-1131.
26. Wang HD, Ren J, Zhang L. CDH1 germline mutation in hereditary gastric carcinoma. World J Gastroenterol. 2004;10:3088-3093.
27. Yoon KA, Ku JL, Yang HK, et al. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet. 1999;44:177-180.